Changing anticoagulation regimens for intracoronary stenting

David Holmes, K. N. Garratt

Research output: Contribution to journalShort survey

3 Citations (Scopus)

Abstract

Traditionally, intensive anticoagulant and antiplatelet regimens have been recommended before, during, and after stent implantation. The primary rationale for these intensive regimens was the prevention of subacute thrombosis, thought to be due largely to the 'thrombogenicity' of the metallic devices. Two recent developments changed this situation: (1) the recognition that bleeding and vascular complications are more common after stent implantation than is subacute closure; and (2) the finding, through the more widespread use of intravascular ultrasound, that stent implantation employing conventional techniques and approaches is often suboptimal. Many investigators reasoned that these suboptimal results, rather than the particular anticoagulant/antiplatelet protocol used, were responsible for subacute closure, and accordingly, changed their anticoagulant/antiplatelet programs to less intensive regimens. These less stringent anticoagulant/antiplatelet regimens have not been rested in prospective, randomized trials, but appear safe based on an increasingly large patient experience.

Original languageEnglish (US)
Pages (from-to)162-165
Number of pages4
JournalJournal of Myocardial Ischemia
Volume7
Issue number4
StatePublished - Jan 1 1995

Fingerprint

Anticoagulants
Stents
Blood Vessels
Thrombosis
Research Personnel
Hemorrhage
Equipment and Supplies

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Changing anticoagulation regimens for intracoronary stenting. / Holmes, David; Garratt, K. N.

In: Journal of Myocardial Ischemia, Vol. 7, No. 4, 01.01.1995, p. 162-165.

Research output: Contribution to journalShort survey

@article{6028ec720084470c9775858b3c9b2d7e,
title = "Changing anticoagulation regimens for intracoronary stenting",
abstract = "Traditionally, intensive anticoagulant and antiplatelet regimens have been recommended before, during, and after stent implantation. The primary rationale for these intensive regimens was the prevention of subacute thrombosis, thought to be due largely to the 'thrombogenicity' of the metallic devices. Two recent developments changed this situation: (1) the recognition that bleeding and vascular complications are more common after stent implantation than is subacute closure; and (2) the finding, through the more widespread use of intravascular ultrasound, that stent implantation employing conventional techniques and approaches is often suboptimal. Many investigators reasoned that these suboptimal results, rather than the particular anticoagulant/antiplatelet protocol used, were responsible for subacute closure, and accordingly, changed their anticoagulant/antiplatelet programs to less intensive regimens. These less stringent anticoagulant/antiplatelet regimens have not been rested in prospective, randomized trials, but appear safe based on an increasingly large patient experience.",
author = "David Holmes and Garratt, {K. N.}",
year = "1995",
month = "1",
day = "1",
language = "English (US)",
volume = "7",
pages = "162--165",
journal = "Journal of Myocardial Ischemia",
issn = "1045-7984",
publisher = "PRR Inc.",
number = "4",

}

TY - JOUR

T1 - Changing anticoagulation regimens for intracoronary stenting

AU - Holmes, David

AU - Garratt, K. N.

PY - 1995/1/1

Y1 - 1995/1/1

N2 - Traditionally, intensive anticoagulant and antiplatelet regimens have been recommended before, during, and after stent implantation. The primary rationale for these intensive regimens was the prevention of subacute thrombosis, thought to be due largely to the 'thrombogenicity' of the metallic devices. Two recent developments changed this situation: (1) the recognition that bleeding and vascular complications are more common after stent implantation than is subacute closure; and (2) the finding, through the more widespread use of intravascular ultrasound, that stent implantation employing conventional techniques and approaches is often suboptimal. Many investigators reasoned that these suboptimal results, rather than the particular anticoagulant/antiplatelet protocol used, were responsible for subacute closure, and accordingly, changed their anticoagulant/antiplatelet programs to less intensive regimens. These less stringent anticoagulant/antiplatelet regimens have not been rested in prospective, randomized trials, but appear safe based on an increasingly large patient experience.

AB - Traditionally, intensive anticoagulant and antiplatelet regimens have been recommended before, during, and after stent implantation. The primary rationale for these intensive regimens was the prevention of subacute thrombosis, thought to be due largely to the 'thrombogenicity' of the metallic devices. Two recent developments changed this situation: (1) the recognition that bleeding and vascular complications are more common after stent implantation than is subacute closure; and (2) the finding, through the more widespread use of intravascular ultrasound, that stent implantation employing conventional techniques and approaches is often suboptimal. Many investigators reasoned that these suboptimal results, rather than the particular anticoagulant/antiplatelet protocol used, were responsible for subacute closure, and accordingly, changed their anticoagulant/antiplatelet programs to less intensive regimens. These less stringent anticoagulant/antiplatelet regimens have not been rested in prospective, randomized trials, but appear safe based on an increasingly large patient experience.

UR - http://www.scopus.com/inward/record.url?scp=0029070290&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029070290&partnerID=8YFLogxK

M3 - Short survey

AN - SCOPUS:0029070290

VL - 7

SP - 162

EP - 165

JO - Journal of Myocardial Ischemia

JF - Journal of Myocardial Ischemia

SN - 1045-7984

IS - 4

ER -